Works matching AU Yee, Ka Lai

Results: 32

Assessment of Bezlotoxumab Immunogenicity.

Published in:

Clinical Pharmacology in Drug Development, 2020, v. 9, n. 3, p. 330, doi. 10.1002/cpdd.729

By:

Montgomery, Diana L.;
Matthews, Randolph P.;
Yee, Ka Lai;
Tobias, Lori M.;
Dorr, Mary Beth;
Wrishko, Rebecca E.

Publication type:

Article

Evaluation of the Pharmacokinetics of Metformin Following Coadministration With Doravirine in Healthy Volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2020, v. 9, n. 1, p. 107, doi. 10.1002/cpdd.685

By:

Sanchez, Rosa I.;
Yee, Ka Lai;
Fan, Li;
Cislak, Dawn;
Martell, Maureen;
Jordan, Heather R.;
Iwamoto, Marian;
Khalilieh, Sauzanne

Publication type:

Article

Dealing With Variable Drug Exposure Due to Variable Hepatic Metabolism: A Proof‐of‐Concept Application of Liquid Biopsy in Renal Impairment.

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 3, p. 814, doi. 10.1002/cpt.3291

By:

Rostami‐Hodjegan, Amin;
Al‐Majdoub, Zubida M.;
von Grabowiecki, Yannick;
Yee, Ka Lai;
Sahoo, Sudhakar;
Breitwieser, Wolfgang;
Galetin, Aleksandra;
Gibson, Christopher;
Achour, Brahim

Publication type:

Article

Coproporphyrin I as an Endogenous Biomarker to Detect Reduced OATP1B Activity and Shift in Elimination Route in Chronic Kidney Disease.

Published in:

Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 3, p. 615, doi. 10.1002/cpt.2672

By:

Takita, Hiroyuki;
Scotcher, Daniel;
Chu, Xiaoyan;
Yee, Ka Lai;
Ogungbenro, Kayode;
Galetin, Aleksandra

Publication type:

Article

A Disease Progression Model to Quantify the Nonmotor Symptoms of Parkinson's Disease in Participants With Leucine‐Rich Repeat Kinase 2 Mutation.

Published in:

Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 2, p. 508, doi. 10.1002/cpt.2277

By:

Ahamadi, Malidi;
Mehrotra, Nitin;
Hanan, Nathan;
Lai Yee, Ka;
Gheyas, Ferdous;
Anton, Judith;
Bani, Massimo;
Boroojerdi, Babak;
Smit, Hans;
Weidemann, Jonas;
Macha, Sreeraj;
Thuillier, Vincent;
Chen, Chao;
Yang, Minhua;
Williams‐Gray, Caroline H.;
Stebbins, Glenn T.;
Pagano, Gennaro;
Hang, Yaming;
Marek, Kenneth;
Venuto, Charles S.

Publication type:

Article

A Microdose Cocktail to Evaluate Drug Interactions in Patients with Renal Impairment.

Published in:

Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 2, p. 403, doi. 10.1002/cpt.1998

By:

Tatosian, Daniel A.;
Yee, Ka Lai;
Zhang, Zufei;
Mostoller, Kate;
Paul, Erina;
Sutradhar, Santosh;
Larson, Patrick;
Chhibber, Aparna;
Wen, Jianzhong;
Wang, Ya‐Juan;
Lassman, Michael;
Latham, Andrew H.;
Pang, Jianmei;
Crumley, Tami;
Gillespie, Anne;
Marricco, Nadia Cardillo;
Marenco, Ted;
Murphy, Matthew;
Lasseter, Kenneth C.;
Marbury, Thomas C.

Publication type:

Article

Integrated Disease Chronicity Modeling to Map Longitudinal Biomarker Relationships in Alzheimer's Disease.

Published in:

Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S2, p. 1, doi. 10.1002/alz.090730

By:

Robey, Seth;
Yee, Ka Lai;
Stone, Julie A

Publication type:

Article

Comparative Bioavailability of Oral Granule Formulations of the HIV Antiretroviral Drugs Doravirine, Lamivudine, and Tenofovir Disoproxil Fumarate.

Published in:

AAPS PharmSciTech, 2020, v. 21, n. 3, p. 1, doi. 10.1208/s12249-020-1630-6

By:

Yee, Ka Lai;
DiBenedetto, Adrienne;
Fan, Li;
Khalilieh, Sauzanne;
Triantafyllou, Ilias;
Vallee, Marie-Helene;
Fackler, Paul;
Stoch, S. Aubrey;
Iwamoto, Marian

Publication type:

Article

A time-to-event analysis of the exposure–response relationship for bezlotoxumab concentrations and CDI recurrence.

Published in:

Journal of Pharmacokinetics & Pharmacodynamics, 2020, v. 47, n. 2, p. 121, doi. 10.1007/s10928-019-09660-5

By:

Yee, Ka Lai;
Kleijn, Huub Jan;
Zajic, Stefan;
Dorr, Mary Beth;
Wrishko, Rebecca E.

Publication type:

Article

Predicting vaccine effectiveness against invasive pneumococcal disease in children using immunogenicity data.

Published in:

NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00538-1

By:

Ryman, Josiah;
Weaver, Jessica;
Hu, Tianyan;
Weinberger, Daniel M.;
Yee, Ka Lai;
Sachs, Jeffrey R.

Publication type:

Article

Potential serotype-specific effectiveness against IPD of pneumococcal conjugate vaccines V114 and PCV20 in children given a 2+1 dosing regimen.

Published in:

Expert Review of Vaccines, 2024, v. 23, n. 1, p. 467, doi. 10.1080/14760584.2024.2335323

By:

Ryman, Josiah;
Sachs, Jeffrey R.;
Banniettis, Natalie;
Weiss, Thomas;
Ahsman, Maurice;
Yee, Ka Lai;
Weaver, Jessica

Publication type:

Article

Predicted serotype-specific effectiveness of pneumococcal conjugate vaccines V114 and PCV20 against invasive pneumococcal disease in children.

Published in:

Expert Review of Vaccines, 2024, v. 23, n. 1, p. 60, doi. 10.1080/14760584.2023.2292773

By:

Ryman, Josiah;
Sachs, Jeffrey R.;
Yee, Ka Lai;
Banniettis, Natalie;
Weaver, Jessica;
Weiss, Thomas

Publication type:

Article

Predicting effectiveness of the V114 vaccine against invasive pneumococcal disease in children.

Published in:

Expert Review of Vaccines, 2022, v. 21, n. 10, p. 1515, doi. 10.1080/14760584.2022.2112179

By:

Ryman, Josiah;
Weaver, Jessica;
Yee, Ka Lai;
Sachs, Jeffrey R.

Publication type:

Article

Erratum to: A Two-Way Steady-State Pharmacokinetic Interaction Study of Doravirine (MK-1439) and Dolutegravir.

Published in:

2017

By:

Anderson, Matt;
Khalilieh, Sauzanne;
Yee, Ka;
Liu, Rachael;
Fan, Li;
Rizk, Matthew;
Shah, Vedangi;
Hussaini, Azra;
Song, Ivy;
Ross, Lisa;
Butterton, Joan;
Anderson, Matt S;
Yee, Ka Lai;
Rizk, Matthew L;
Ross, Lisa L;
Butterton, Joan R

Publication type:

journal article

A Two-Way Steady-State Pharmacokinetic Interaction Study of Doravirine (MK-1439) and Dolutegravir.

Published in:

2017

By:

Anderson, Matt;
Khalilieh, Sauzanne;
Yee, Ka;
Liu, Rachael;
Fan, Li;
Rizk, Matthew;
Shah, Vedangi;
Hussaini, Azra;
Song, Ivy;
Ross, Lisa;
Butterton, Joan;
Anderson, Matt S;
Yee, Ka Lai;
Rizk, Matthew L;
Ross, Lisa L;
Butterton, Joan R

Publication type:

journal article

The duration of sleep promoting efficacy by dual orexin receptor antagonists is dependent upon receptor occupancy threshold.

Published in:

BMC Neuroscience, 2013, v. 14, n. 1, p. 1, doi. 10.1186/1471-2202-14-90

By:

Gotter, Anthony L.;
Winrow, Christopher J.;
Brunner, Joseph;
Garson, Susan L.;
Fox, Steven V.;
Binns, Jacquelyn;
Harrell, Charles M.;
Donghui Cui;
Ka Lai Yee;
Mark Stiteler, Mark Stiteler;
Stevens, Joanne;
Savitz, Alan;
Tannenbaum, Pamela L.;
Tye, Spencer J.;
McDonald, Terrence;
Leon Yao;
Kuduk, Scott D.;
Uslaner, Jason;
Coleman, Paul J.;
Renger, John J.

Publication type:

Article

The duration of sleep promoting efficacy by dual orexin receptor antagonists is dependent upon receptor occupancy threshold.

Published in:

2013

By:

Gotter, Anthony L;
Winrow, Christopher J;
Brunner, Joseph;
Garson, Susan L;
Fox, Steven V;
Binns, Jacquelyn;
Harrell, Charles M;
Cui, Donghui;
Yee, Ka Lai;
Stiteler, Mark;
Stevens, Joanne;
Savitz, Alan;
Tannenbaum, Pamela L;
Tye, Spencer J;
McDonald, Terrence;
Yao, Leon;
Kuduk, Scott D;
Uslaner, Jason;
Coleman, Paul J;
Renger, John J

Publication type:

journal article

PBPK-PD modeling for the preclinical development and clinical translation of tau antibodies for Alzheimer's disease.

Published in:

Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.867457

By:

Bloomingdale, Peter;
Bumbaca-Yadav, Daniela;
Sugam, Jonathan;
Grauer, Steve;
Smith, Brad;
Antonenko, Svetlana;
Judo, Michael;
Azadi, Glareh;
Ka Lai Yee

Publication type:

Article

Clinical Pharmacokinetics of the Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor Doravirine: An Assessment of the Effect of Patient Characteristics and Drug–Drug Interactions.

Published in:

Clinical Drug Investigation, 2020, v. 40, n. 10, p. 927, doi. 10.1007/s40261-020-00934-2

By:

Khalilieh, Sauzanne;
Yee, Ka Lai;
Sanchez, Rosa;
Stoch, S. Aubrey;
Wenning, Larissa;
Iwamoto, Marian

Publication type:

Article

Correction to: Effect of CYP3A Inhibition and Induction on the Pharmacokinetics of Suvorexant: Two Phase I, Open-Label, Fixed-Sequence Trials in Healthy Subjects.

Published in:

2019

By:

Wrishko, Rebecca E.;
McCrea, Jacqueline B.;
Yee, Ka Lai;
Liu, Wen;
Panebianco, Deborah;
Mangin, Eric;
Chakravarthy, Manu;
Martinez-Cantarin, Maria P.;
Kraft, Walter K.

Publication type:

Correction Notice

Effect of CYP3A Inhibition and Induction on the Pharmacokinetics of Suvorexant: Two Phase I, Open-Label, Fixed-Sequence Trials in Healthy Subjects.

Published in:

Clinical Drug Investigation, 2019, v. 39, n. 5, p. 441, doi. 10.1007/s40261-019-00764-x

By:

Wrishko, Rebecca E.;
McCrea, Jacqueline B.;
Yee, Ka Lai;
Liu, Wen;
Panebianco, Deborah;
Mangin, Eric;
Chakravarthy, Manu;
Martinez-Cantarin, Maria P.;
Kraft, Walter K.

Publication type:

Article

Safety, Tolerability, and Pharmacokinetics of Suvorexant: A Randomized Rising-Dose Trial in Healthy Men.

Published in:

Clinical Drug Investigation, 2018, v. 38, n. 7, p. 631, doi. 10.1007/s40261-018-0650-4

By:

Yee, Ka Lai;
McCrea, Jacqueline;
Panebianco, Deborah;
Liu, Wen;
Lewis, Nicole;
Cabalu, Tamara;
Ramael, Steven;
Wrishko, Rebecca E.

Publication type:

Article

Psychomotor effects, pharmacokinetics and safety of the orexin receptor antagonist suvorexant administered in combination with alcohol in healthy subjects.

Published in:

2015

By:

Sun, Hong;
Yee, Ka Lai;
Gill, Sean;
Liu, Wen;
Li, Xiaodong;
Panebianco, Deborah;
Mangin, Eric;
Morrison, Dennis;
McCrea, Jacqueline;
Wagner, John A.;
Troyer, Matthew D.

Publication type:

journal article

Pharmacokinetics, safety and tolerability of long‐acting parenteral intramuscular injection formulations of doravirine.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2020, v. 45, n. 5, p. 1098, doi. 10.1111/jcpt.13182

By:

Yee, Ka Lai;
Mittal, Sachin;
Fan, Li;
Triantafyllou, Ilias;
Dockendorf, Marissa F.;
Fackler, Paul H.;
Stoch, S. Aubrey;
Khalilieh, Sauzanne G.;
Iwamoto, Marian

Publication type:

Article

Physiologically Based Pharmacokinetic Modeling of Doravirine and Its Major Metabolite to Support Dose Adjustment With Rifabutin.

Published in:

Journal of Clinical Pharmacology, 2021, v. 61, n. 3, p. 394, doi. 10.1002/jcph.1747

By:

Yee, Ka Lai;
Cabalu, Tamara D.;
Kuo, Yuhsin;
Fillgrove, Kerry L.;
Liu, Yang;
Triantafyllou, Ilias;
McClain, Sasha;
Dreyer, Daniel;
Wenning, Larissa;
Stoch, S. Aubrey;
Iwamoto, Marian;
Sanchez, Rosa I.;
Khalilieh, Sauzanne G.

Publication type:

Article

A Study to Evaluate Doravirine Pharmacokinetics When Coadministered With Acid‐Reducing Agents.

Published in:

Journal of Clinical Pharmacology, 2019, v. 59, n. 8, p. 1093, doi. 10.1002/jcph.1399

By:

Khalilieh, Sauzanne G.;
Yee, Ka Lai;
Sanchez, Rosa I.;
Fan, Li;
Vaynshteyn, Kate;
Deschamps, Kathleen;
Martell, Maureen;
Jordan, Heather R.;
Iwamoto, Marian

Publication type:

Article

Multiple Doses of Rifabutin Reduce Exposure of Doravirine in Healthy Subjects.

Published in:

Journal of Clinical Pharmacology, 2018, v. 58, n. 8, p. 1044, doi. 10.1002/jcph.1103

By:

Khalilieh, Sauzanne G.;
Yee, Ka Lai;
Sanchez, Rosa I.;
Liu, Rachel;
Fan, Li;
Martell, Maureen;
Jordan, Heather;
Iwamoto, Marian

Publication type:

Article

Evaluation of Model‐Based Prediction of Pharmacokinetics in the Renal Impairment Population.

Published in:

Journal of Clinical Pharmacology, 2018, v. 58, n. 3, p. 364, doi. 10.1002/jcph.1022

By:

Yee, Ka Lai;
Li, Mengyao;
Cabalu, Tamara;
Sahasrabudhe, Vaishali;
Lin, Jian;
Zhao, Ping;
Jadhav, Pravin

Publication type:

Article

Moderate Hepatic Impairment Does Not Affect Doravirine Pharmacokinetics.

Published in:

Journal of Clinical Pharmacology, 2017, v. 57, n. 6, p. 777, doi. 10.1002/jcph.857

By:

Khalilieh, Sauzanne;
Yee, Ka Lai;
Liu, Rachael;
Fan, Li;
Sanchez, Rosa I.;
Auger, Patrice;
Triantafyllou, Ilias;
Stypinski, Daria;
Lasseter, Kenneth C.;
Marbury, Thomas;
Iwamoto, Marian

Publication type:

Article

Characterisation of the absorption, distribution, metabolism, excretion and mass balance of doravirine, a non-nucleoside reverse transcriptase inhibitor in humans.

Published in:

Xenobiotica, 2019, v. 49, n. 4, p. 422, doi. 10.1080/00498254.2018.1451667

By:

Sanchez, Rosa I.;
Fillgrove, Kerry L.;
Yee, Ka Lai;
Liang, Yuexia;
Lu, Bing;
Tatavarti, Aditya;
Liu, Rachael;
Anderson, Matt S.;
Behm, Martin O.;
Fan, Li;
Li, Yun;
Butterton, Joan R.;
Iwamoto, Marian;
Khalilieh, Sauzanne G.

Publication type:

Article

In vitro and in vivo characterisation of the metabolism and disposition of suvorexant in humans.

Published in:

Xenobiotica, 2016, v. 46, n. 10, p. 882, doi. 10.3109/00498254.2015.1129565

By:

Cui, Donghui;
Cabalu, Tamara;
Yee, Ka Lai;
Small, James;
Li, Xiaodong;
Liu, Bo;
Maciolek, Cheri;
Smith, Sheri;
Liu, Wen;
McCrea, Jacqueline B.;
Prueksaritanont, Thomayant

Publication type:

Article

Orexin 2 Receptor Antagonism is Sufficient to Promote NREM and REM Sleep from Mouse to Man.

Published in:

Scientific Reports, 2016, p. 27147, doi. 10.1038/srep27147

By:

Gotter, Anthony L.;
Forman, Mark S.;
Harrell, Charles M.;
Stevens, Joanne;
Svetnik, Vladimir;
Yee, Ka Lai;
Li, Xiaodong;
Roecker, Anthony J.;
Fox, Steven V.;
Tannenbaum, Pamela L.;
Garson, Susan L.;
Lepeleire, Inge De;
Calder, Nicole;
Rosen, Laura;
Struyk, Arie;
Coleman, Paul J.;
Herring, W. Joseph;
Renger, John J.;
Winrow, Christopher J.

Publication type:

Article